Source comparison
BPC-157 Tendon Healing Research: Dosing Approaches Comparison
10 mcg/kg daily, days 0–14 Functional recovery 40% faster vs controls Intraperitoneal injection Invasive route impractical for human research; requires sterile technique Most studied protocol; consistent outcomes across multiple trials 5 mcg/kg daily, days 0–2
This comparison does not assign a generated winner or score.
- 10 mcg/kg daily, days 0–14
- Functional recovery 40% faster vs controls
- Intraperitoneal injection
- Invasive route impractical for human research; requires sterile technique
- Most studied protocol; consistent outcomes across multiple trials
- 5 mcg/kg daily, days 0–28
- 30% faster recovery; sustained through remodeling phase
- Subcutaneous (local)
- Localized delivery may reduce systemic exposure; injection site rotation required
- Lower dose effective when extended; local delivery showed fewer adhesions
- 10 mcg/kg daily, oral
- 25–35% faster recovery; variable absorption
- Oral gavage
- Non-invasive; peptide stability in gastric environment confirmed
- Bioavailability lower than injection; dosing consistency harder to control
- Delayed initiation (day 7+)
- 15–20% improvement vs controls
- Misses early inflammatory phase; reduced angiogenic window
- Late treatment less effective; supports earlier intervention hypothesis